Dublin, June 28, 2018 (GLOBE NEWSWIRE) -- The "Global Atrial Fibrillation Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering. The research provides insights into Atrial Fibrillation epidemiology, Atrial Fibrillation diagnosed patients, and Atrial Fibrillation treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Atrial Fibrillation derived from epidemiological analysis, patients diagnosed with Atrial Fibrillation, and patients treated with a drug therapy. The research study helps executives estimate Atrial Fibrillation market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The research provides estimates and forecasts of Atrial Fibrillation prevalence, Atrial Fibrillation diagnosis rate, and Atrial Fibrillation treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. Key Features of the Report
- Atrial Fibrillation Patient Flow
- Atrial Fibrillation Prevalence
- Atrial Fibrillation Diagnosed Patients
- Atrial Fibrillation Treated Patients
Key Topics Covered 1. Atrial Fibrillation: Disease Definition 2. Global Atrial Fibrillation Patient Flow 2A. Global Atrial Fibrillation Prevalence 2B. Global Atrial Fibrillation Diagnosed Patients 2C. Global Atrial Fibrillation Treated Patients 3. Atrial Fibrillation Patient Flow in the US 3A. Atrial Fibrillation Prevalence in the US 3B. Atrial Fibrillation Diagnosed Patients in the US 3C. Atrial Fibrillation Treated Patients in the US 4. Atrial Fibrillation Patient Flow in Europe 4A. Atrial Fibrillation Prevalence in Europe 4B. Atrial Fibrillation Diagnosed Patients in Europe 4C. Atrial Fibrillation Treated Patients in Europe 5. Atrial Fibrillation Patient Flow in Germany 5A. Atrial Fibrillation Prevalence in Germany 5B. Atrial Fibrillation Diagnosed Patients in Germany 5C. Atrial Fibrillation Treated Patients in Germany 6. Atrial Fibrillation Patient Flow in France 6A. Atrial Fibrillation Prevalence in France 6B. Atrial Fibrillation Diagnosed Patients in France 6C. Atrial Fibrillation Treated Patients in France 7. Atrial Fibrillation Patient Flow in Spain 7A. Atrial Fibrillation Prevalence in Spain 7B. Atrial Fibrillation Diagnosed Patients in Spain 7C. Atrial Fibrillation Treated Patients in Spain 8. Atrial Fibrillation Patient Flow in Italy 8A. Atrial Fibrillation Prevalence in Italy 8B. Atrial Fibrillation Diagnosed Patients in Italy 8C. Atrial Fibrillation Treated Patients in Italy 9. Atrial Fibrillation Patient Flow in UK 9A. Atrial Fibrillation Prevalence in UK 9B. Atrial Fibrillation Diagnosed Patients in UK 9C. Atrial Fibrillation Treated Patients in UK 10. Atrial Fibrillation Patient Flow in Japan 10A. Atrial Fibrillation Prevalence in Japan 10B. Atrial Fibrillation Diagnosed Patients in Japan 10C. Atrial Fibrillation Treated Patients in Japan 11. Research Methodology For more information about this report visit https://www.researchandmarkets.com/research/5...trial?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Cardiovascular Drugs
